A Study on the Significance of Biomarker Diagnosis in Patients with Suspected Dementia

A Study on the Significance of Biomarker Diagnosis in Patients with Suspected Dementia - FBDSD study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044819

Enrollment

Registered

2021-07-12

Start date

2021-07-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed with normal, MCI, and mild Alzheimer's disease as a result of diagnosis and examination performed within the scope of usual medical diagnosis

Exclusion criteria

Exclusion criteria: Psychiatric disorders other than dementia, cerebrovascular disorders that may affect cognitive function, suspected neurodegenerative disorders other than Alzheimer's disease, cases of delirium or drug-induced cognitive dysfunction

Design outcomes

Primary

Measure	Time frame
Comparison of clinical diagnosis and biomarker diagnosis	—

Countries

Japan

Contacts

Public ContactHajime Takechi

Fujita Health University School of Medicine Department of Geriatrics and Cognitive Disorders

takechi@fujita-hu.ac.jp0562-93-2000

Outcome results